| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8220075 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 8 Pages |
Abstract
Rigosertib was more effective than cisplatin when combined with radiation and caused minimal toxicity. These data support the need for clinical trials with rigosertib in combination therapy for patients with cervical carcinoma.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Lorenzo MD, PhD, Indranil PhD, Seema PhD, Alan MS, Angela MD, Gary L. MD, E. Premkumar PhD, Chandan MBBS, PhD,